176 studies found for:    "Gastrointestinal Stromal Tumors"
Show Display Options
Rank Status Study
1 Completed Gastrointestinal Stromal Tumors (GIST) Registry
Condition: Gastrointestinal Stromal Tumors
Intervention: Other: GIST Registry
2 Completed Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Glivec
3 Completed Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
Condition: Gastrointestinal Stromal Tumors
Intervention:
4 Completed Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Everolimus + Imatinib
5 Completed Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib Mesylate
6 Completed Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: AMN107, STI571
7 Active, not recruiting Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors
Conditions: Advanced Renal Cell Carcinoma;   Gastrointestinal Stromal Tumors;   Pancreatic Neuroendocrine Tumors
Intervention: Drug: TH-302
8 Recruiting Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib
Condition: Advanced Gastrointestinal Stromal Tumors
Intervention: Drug: PD-0332991 will be administrated orally, formulated as gelatin capsules of 100 mg and 25 mg respectively.
9 Completed Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Nilotinib
10 Recruiting A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Masitinib;   Drug: Sunitinib
11 Completed
Has Results
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).
Conditions: Gastrointestinal Stromal Tumors;   Soft Tissue Sarcomas
Intervention: Drug: AZD2171
12 Recruiting A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: masitinib (AB1010);   Drug: imatinib
13 Active, not recruiting Symptom Inventory for Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Interventions: Behavioral: Questionnaires;   Behavioral: Interview;   Behavioral: MDASI-GIST Questionnaire
14 Terminated Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Drug: sunitinib malate;   Other: pharmacological study
15 Terminated
Has Results
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
Conditions: Gastrointestinal Stromal Tumors,;   Cancer,;   Solid Tumors
Interventions: Drug: Peginterferon-alpha 2b (PegIFNa2b);;   Drug: Imatinib
16 Completed S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: temozolomide
17 Completed
Has Results
Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo
Condition: Gastrointestinal Stromal Tumors
Intervention: Other: Observation
18 Active, not recruiting Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: dasatinib
19 Completed Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: imatinib mesylate
20 Active, not recruiting Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Nilotinib

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years